Hexagon Capital Partners’s Aurora Cannabis ACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-200
Closed -$878 88
2025
Q1
$878 Hold
200
﹤0.01% 1573
2024
Q4
$850 Hold
200
﹤0.01% 1618
2024
Q3
$1.18K Hold
200
﹤0.01% 1311
2024
Q2
$924 Hold
200
﹤0.01% 1276
2024
Q1
$878 Hold
200
﹤0.01% 1292
2023
Q4
$953 Sell
200
-50
-20% -$241 ﹤0.01% 1237
2023
Q3
$1.46K Hold
250
﹤0.01% 1125
2023
Q2
$1.34K Hold
250
﹤0.01% 1141
2023
Q1
$1.74K Hold
250
﹤0.01% 1094
2022
Q4
$2.31K Sell
250
-30
-11% -$358 ﹤0.01% 1062
2022
Q3
$3K Buy
280
+140
+100% +$2.06K ﹤0.01% 998
2022
Q2
$2K Hold
140
﹤0.01% 933
2022
Q1
$6K Hold
140
﹤0.01% 684
2021
Q4
$8K Hold
140
﹤0.01% 621
2021
Q3
$10K Hold
140
﹤0.01% 585
2021
Q2
$13K Hold
140
﹤0.01% 523
2021
Q1
$13K Buy
+140
New +$15.6K ﹤0.01% 486

Other funds holding ACB

Hexagon Capital Partners's ACB Position: Q2 2025 in Review

Hexagon Capital Partners sold out of Aurora Cannabis (ACB) in Q2 2025, closing a stake of 200 shares — an estimated $878 sold.

Hexagon Capital Partners first reported a position in ACB in Q1 2021 and held it in 17 quarters. The position peaked at $13K in Q2 2021. 158 funds tracked by Wall St. Rank hold ACB as of Q2 2025.

  • Hexagon Capital Partners reported no remaining Aurora Cannabis position as of Q2 2025 after selling out during the quarter.
  • Hexagon Capital Partners sold 200 Aurora Cannabis shares in Q2 2025, an estimated $878.
  • Hexagon Capital Partners first reported a position in Aurora Cannabis in Q1 2021 and held it in 17 quarters.
  • Hexagon Capital Partners's Aurora Cannabis position peaked at $13K in Q2 2021.
  • 158 funds tracked by Wall St. Rank held Aurora Cannabis as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.